1: Schulz WA, Hoffmann MJ. Epigenetic mechanisms in the biology of prostate
cancer. Semin Cancer Biol. 2009 Jun;19(3):172-80. Epub 2009 Feb 20. Review.
PubMed PMID: 19429481.
2: Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz
WA, Singal R. Methylation-mediated repression of GADD45alpha in prostate cancer
and its role as a potential therapeutic target. Cancer Res. 2009 Feb
(…)
1: Schulz WA, Hoffmann MJ. Epigenetic mechanisms in the biology of prostate
cancer. Semin Cancer Biol. 2009 Jun;19(3):172-80. Epub 2009 Feb 20. Review.
PubMed PMID: 19429481.
2: Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz
WA, Singal R. Methylation-mediated repression of GADD45alpha in prostate cancer
and its role as a potential therapeutic target. Cancer Res. 2009 Feb
15;69(4):1527-35. Epub 2009 Feb 3. PubMed PMID: 19190346.
3: Dokun OY, Florl AR, Seifert HH, Wolff I, Schulz WA. Relationship of SNCG,
S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer.
Int J Cancer. 2008 Dec 15;123(12):2798-807. PubMed PMID: 18803290.
4: Hoffmann MJ, Engers R, Florl AR, Otte AP, Muller M, Schulz WA. Expression
changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA
methylation changes in prostate cancer. Cancer Biol Ther. 2007 Sep;6(9):1403-12.
PubMed PMID: 18637271.
5: Hornstein M, Hoffmann MJ, Alexa A, Yamanaka M, Müller M, Jung V, Rahnenführer
J, Schulz WA. Protein phosphatase and TRAIL receptor genes as new candidate tumor
genes on chromosome 8p in prostate cancer. Cancer Genomics Proteomics. 2008
Mar-Apr;5(2):123-36. PubMed PMID: 18460741.
6: Sieron P, Hader C, Hatina J, Engers R, Wlazlinski A, Müller M, Schulz WA. DKC1
overexpression associated with prostate cancer progression. Br J Cancer. 2009 Sep
15. [Epub ahead of print] PubMed PMID: 19755982.
7: Florl AR, Schulz WA. Chromosomal instability in bladder cancer. Arch Toxicol.
2008 Mar;82(3):173-82. Epub 2008 Feb 6. Review. PubMed PMID: 18253719.
8: Schulz WA, Hoffmann MJ. Transcription factor networks in embryonic stem cells
and testicular cancer and the definition of epigenetics. Epigenetics. 2007
Jan-Mar;2(1):37-42. Epub 2007 Feb 27. Review. PubMed PMID: 17965618.
9: Neveling K, Kalb R, Florl AR, Herterich S, Friedl R, Hoehn H, Hader C,
Hartmann FH, Nanda I, Steinlein C, Schmid M, Tonnies H, Hurst CD, Knowles MA,
Hanenberg H, Schulz WA, Schindler D. Disruption of the FA/BRCA pathway in bladder
cancer. Cytogenet Genome Res. 2007;118(2-4):166-76. PubMed PMID: 18000367.
10: Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, Müller M, Schulz WA.
Downregulation of several fibulin genes in prostate cancer. Prostate. 2007 Dec
1;67(16):1770-80. PubMed PMID: 17929269.
11: Schulz WA, Alexa A, Jung V, Hader C, Hoffmann MJ, Yamanaka M, Fritzsche S,
Wlazlinski A, Müller M, Lengauer T, Engers R, Florl AR, Wullich B, Rahnenführer
J. Factor interaction analysis for chromosome 8 and DNA methylation alterations
highlights innate immune response suppression and cytoskeletal changes in
prostate cancer. Mol Cancer. 2007 Feb 5;6:14. PubMed PMID: 17280610; PubMed
Central PMCID: PMC1797054.
12: Seifert HH, Schmiemann V, Mueller M, Kazimirek M, Onofre F, Neuhausen A,
Florl AR, Ackermann R, Boecking A, Schulz WA, Grote HJ. In situ detection of
global DNA hypomethylation in exfoliative urine cytology of patients with
suspected bladder cancer. Exp Mol Pathol. 2007 Jun;82(3):292-7. Epub 2006 Oct 5.
PubMed PMID: 17026997.
13: Fritzsche S, Kenzelmann M, Hoffmann MJ, Müller M, Engers R, Gröne HJ, Schulz
WA. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma. Endocr
Relat Cancer. 2006 Sep;13(3):839-49. PubMed PMID: 16954433.
14: Schulz WA, Steinhoff C, Florl AR. Methylation of endogenous human
retroelements in health and disease. Curr Top Microbiol Immunol. 2006;310:211-50.
Review. PubMed PMID: 16909913.
15: Schulz WA. L1 retrotransposons in human cancers. J Biomed Biotechnol.
2006;2006(1):83672. PubMed PMID: 16877821; PubMed Central PMCID: PMC1559935.
16: Hoffmann MJ, Müller M, Engers R, Schulz WA. Epigenetic control of CTCFL/BORIS
and OCT4 expression in urogenital malignancies. Biochem Pharmacol. 2006 Nov
30;72(11):1577-88. Epub 2006 Jul 18. PubMed PMID: 16854382.
17: Neuhausen A, Florl AR, Grimm MO, Schulz WA. DNA methylation alterations in
urothelial carcinoma. Cancer Biol Ther. 2006 Aug;5(8):993-1001. Epub 2006 Aug 4.
PubMed PMID: 16775427.
18: Schulz WA, Hatina J. Epigenetics of prostate cancer: beyond DNA methylation.
J Cell Mol Med. 2006 Jan-Mar;10(1):100-25. Review. PubMed PMID: 16563224.
19: Schulz WA. Understanding urothelial carcinoma through cancer pathways. Int J
Cancer. 2006 Oct 1;119(7):1513-8. Review. PubMed PMID: 16557569.
20: Wethkamp N, Ramp U, Geddert H, Schulz WA, Florl AR, Suschek CV, Hassan M,
Gabbert HE, Mahotka C. Expression of death-associated protein kinase during
tumour progression of human renal cell carcinomas: hypermethylation-independent
mechanisms of inactivation. Eur J Cancer. 2006 Jan;42(2):264-74. Epub 2006 Jan 4.
PubMed PMID: 16386893.
